Sparks set to fly at Australian hearing on access to cancer drugs
This article was originally published in Scrip
A public hearing is to be held in Canberra on 20 April as part of a review of patient access to new, innovative and specialist cancer drugs in Australia that is being conducted by the Senate's Community Affairs References Committee.
You may also be interested in...
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
The UK’s rapid authorization of the Pfizer/BioNTech COVID-19 vaccine has sparked a public debate over regulatory processes at some of the world’s key regulatory bodies.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.